In vivo data on IHL-675A supports expansion of indications to include COPD and asthma Feb. 8, 2021 No Comments
Phase II trial of ensifentrine pMDI formulation in COPD meets lung function endpoints Feb. 2, 2021 No Comments
Ampio expands phase I trial of Ampion for COVID-19 respiratory distress based on early data Feb. 2, 2021 No Comments
First patient dosed in second phase II study of AD-109 in obstructive sleep apnea Jan. 20, 2021 No Comments
Phase II trial of dexpramipexole in moderate to severe eosinophilic asthma meets primary endpoint Jan. 14, 2021 No Comments
RSS